Verastem, Inc.
Symbol: VSTM (NASDAQ)
8.27
▲ (6.97%) 0.539
Company Description:
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Key Stats
- Today's Open: $7.53
- Today's High: $8.295
- Today's Low: $7.51
- Today's Volume: 2.85M
- Yesterday Close: $7.73
- Yesterday High: $8.356
- Yesterday Low: $7.44
- Yesterday Volume: 3.66M
- Last Min Volume: 1
- Last Min High: $8.269
- Last Min Low: $8.262
- Last Min VWAP: $8.262
Company Profile
- Name: Verastem, Inc.
- Website: https://www.verastem.com
- Listed Date: 2012-01-27
- Location: NEEDHAM, MA
- Market Status: Active
- CIK Number: 0001526119
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $475.74M
- Round Lot: 100
- Outstanding Shares: 61.55M
- Asset Type: CS
RECENT FILINGS FOR VSTM
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-13 | 8-K | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-08-12 | S-3/A | View |
| 2025-08-08 | S-3 | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-06 | 4 | View |
| 2025-08-06 | SCHEDULE 13G | View |
| 2025-07-29 | SCHEDULE 13G/A | View |
| 2025-07-29 | SCHEDULE 13G | View |
| 2025-07-28 | SCHEDULE 13G | View |
| 2025-07-28 | SCHEDULE 13G | View |
| 2025-06-24 | 4 | View |
| 2025-06-24 | 4 | View |
| 2025-06-20 | 144 | View |
| 2025-06-20 | 4 | View |
Latest News on VSTM